Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huatai Biopharm is a leading global manufacturer specializing in high-purity Omega-3 fatty acids, specifically EPA and DHA APIs and concentrates. Headquartered in Chengdu, China, the company operates state-of-the-art cGMP facilities that have successfully undergone inspections by the US FDA, EDQM, and TGA. Huatai Biopharm offers a robust portfolio of pharmaceutical-grade lipid products, including ethyl esters and triglycerides, produced using advanced purification technologies like supercritical fluid chromatography. The company serves the global pharmaceutical and nutraceutical markets, supporting therapeutic areas such as cardiovascular health and metabolic disorders through high-concentration active ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huatai Biopharm.